Mutations in CIC and FUBP1 contribute to human oligodendroglioma - Test2 - elhamkhani - TriplyDB

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

http://www.wikidata.org/entity/Q28244895

about

The spectrum of SWI/SNF mutations, ubiquitous in human cancers NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma Recent advances in the molecular understanding of glioblastoma In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies Oligodendroglioma: pathology, molecular mechanisms and markers EGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell Proliferation via Capicua-Regulated Genes Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.The epidemiology of glioma in adults: a "state of the science" review ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization Detection of circulating tumor DNA in early- and late-stage human malignancies Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas The genetic landscape of anaplastic astrocytoma.Molecular Testing of Brain Tumor.Integrated analysis of recurrent properties of cancer genes to identify novel drivers Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA.Quantitative iTRAQ LC-MS/MS Proteomics Reveals Transcription Factor Crosstalk and Regulatory Networks in Hypopharyngeal Squamous Cell Carcinoma Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.Genetic landscape of extreme responders with anaplastic oligodendroglioma.Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.FBP1 Is an Interacting Partner of Menin.Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.Medical therapy of gliomas.Cancer genomics and pathology: all together now.Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis.Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas.TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.A mathematical model for short-term vs. long-term survival in patients with glioma.

P2860

Q21090801-A351AB20-A85F-4D0B-BD89-9717903453D9 Q24596715-5BBCFE52-4927-4CC2-A883-47B744867780 Q24630017-C4BB7FC2-74CE-4493-B178-15550F0B9FCD Q24632928-9F223DC9-C417-4D0D-A936-01FF48EB1C43 Q26820289-2E933776-D6B1-4961-BC25-37820D819E6B Q27002448-83015BC2-72CA-4FE6-A372-E7BC21F0FED2 Q27310105-5C608EC0-AE45-41FF-B9C9-B3BF845315E5 Q27853175-0BC3244E-316D-43DE-8956-AFF7091EC4F9 Q28387839-EFE14266-FDFC-47E3-B8BF-FF7A44A2906C Q28593691-2A9E7E15-4921-4266-A469-B32A86823D14 Q29615778-3F56219E-E76F-441C-9A05-3E87177C041C Q30370204-D0BDF9A0-BDD4-4512-A62C-B33DEA01F3FB Q30542081-DDFF545B-6903-4777-86D0-D1ECEAC49138 Q30836702-29CB0817-C5DB-49F6-8F90-DBC247F21F8E Q33554186-4B23A4A3-34F8-439D-9763-763A3D48F3BA Q33688888-12983646-E73F-40FB-9893-6A88188F3851 Q33729693-E5638E1D-A206-4D3B-94B1-5F920BE97CCD Q33742981-0DEFD169-8A01-4399-A230-51F4A21B58EB Q33746514-EFBF5371-00DB-4CDD-B0AF-33247DB0786D Q33757037-FE26B362-D8AD-4B74-8396-73AE3CFAD144 Q33792857-F76F87BA-AD02-45F1-B683-DABE3B463E64 Q33794367-8FC70B52-3E5F-47E9-B3EA-4972CFAC2157 Q33804713-51B3273E-B4E7-44F6-AF21-604063FF3CC2 Q33829209-E089121E-BB6F-4215-815E-5111A64CEEFD Q33835854-7C9887C0-5888-44B9-8FE7-86F51DC25AC5 Q33894486-0F025650-5F55-4DA5-81CF-2436EDD0735B Q33925544-E295D240-485A-4854-8701-6C7AAC1DAA53 Q33938943-26A7B074-B015-46FB-B778-7299E7212513 Q34009803-1A2AEEB9-2649-44BC-BA33-190CA529BD6C Q34091425-A07F4AAA-0C6C-4482-A105-816AB0D1FEF2 Q34218761-618F89D6-0480-4D66-8858-E21E1DAACE43 Q34301519-868EACA0-2074-4FB7-926E-7819F9795B07 Q34332857-87C02D1B-E198-410B-8AA4-6C9457127F54 Q34359802-03D3E54F-4872-4804-8319-0384BB6620CD Q34362617-300A4758-8BBD-4557-97E7-5FB6414358A9 Q34365966-F54D5696-DEDA-4D51-9B6B-D949870D5275 Q34446905-A837373B-CB31-41C1-9843-FD210EA919FD Q34499685-87636900-4A04-4833-8126-CF768C239FBA Q34635517-D37995A6-657B-4B72-89E1-153D60680DA5 Q34704964-2654BEA5-34C7-420C-BECC-100A2579A481

P2860

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

http://www.wikidata.org/entity/Q28244895

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@ast

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@en

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@nl

type

label

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@ast

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@en

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@nl

prefLabel

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@ast

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@en

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@nl

P1433

Q28244895-08640ABC-DD20-426E-A888-6454C0DFA510

P1476

Q28244895-3E56E4EA-3D13-45B8-998F-BEFCE42F872E

P2093

Q28244895-1B17B057-B665-4460-AC73-D6C4E247097A

Q28244895-29FFB494-C110-46F7-9E74-2B2B2CDC2FEE

Q28244895-4497E69C-CEAF-432F-9937-8E91726091C5

Q28244895-4F070CA7-777A-4340-81C0-460A2B200955

Q28244895-5B177C3F-A0DA-42FA-84EF-9319814299F6

Q28244895-930D7D68-AC0B-45B0-A077-723DBE639889

Q28244895-B4264AE3-D51C-4F4B-963E-2D1B0B453836

Q28244895-BC7EE9C5-AD39-45DB-A950-67271D760F8B

Q28244895-BF6F01FD-5914-4797-859E-950F0DB069F4

Q28244895-D82DCBC9-F312-4C18-8423-E8B5C9B4D0AD

P2860

Q28244895-03C413F8-2B4E-4C6E-9719-C5068CFC95F5

Q28244895-0CDF467A-98B1-4C23-90EA-EE392A1E940A

Q28244895-188C2873-FDF6-49A5-945D-9F7910F5E327

Q28244895-28E9AD3E-C531-48E8-901C-54D905DDF8EF

Q28244895-2D15241A-59D0-4D1F-9F09-61BC54EF7967

Q28244895-328E49AB-C977-4156-A7C4-4469B058D432

Q28244895-41594BB6-C9AC-4517-93A9-F833B0CEB3BC

Q28244895-46C70CD8-F85A-4D0B-9FF4-0D2335509ED5

Q28244895-5321CE93-1B76-4F4C-8CC2-3479AA79FD22

Q28244895-5CB11471-77C9-45DC-B2CA-17CB934CAD29

P304

Q28244895-0B8FCD2A-5081-481A-B2DC-C623FED0DBA7

P31

Q28244895-8CFC74BB-44DD-44E9-B172-28083CD15A79

P3181

Q28244895-7C374114-423B-42C4-A394-006DAADF3194

P356

Q28244895-48975D25-AEF0-46C8-BBE1-8A708A6E54F5

P407

Q28244895-1BEA09D6-E31D-4E61-A2C3-9BD871DD25E6

P433

Q28244895-2A375991-7D1B-49F8-9FFD-D8DAFD24EDF7

P478

Q28244895-06EB6276-5A30-4B07-9C9F-65E9E7A3DEC9

P50

Q28244895-8D2AE4B9-20F6-4772-92DA-86D3F11AADF6

Q28244895-A7BDDD12-4476-4486-9A5B-EC18E4675447

Q28244895-AEBB8277-49F5-491E-854B-B9715AEC4F43

Q28244895-B97998C2-F219-4A2D-810F-E07B1297CD5D

Q28244895-BD44A97C-C9B1-4870-9891-2E94049C917C

Q28244895-E438200A-82A1-41CA-8C7E-1B3A0CAA32B7

Q28244895-F7F6E061-2F8A-41BF-996E-C5CBB6A9AC56

P577

Q28244895-90D042D4-4524-4301-B4E8-E0B483643ABE

P5875

Q28244895-8265F2F6-C35C-45F1-84F0-6F8998051552

P698

Q28244895-B58467FB-C3C8-4E05-831E-B8C471DB0316

P921

Q28244895-40DAE49D-26F8-4025-BAD8-5F2D9F5DA02E

P932

Q28244895-F5C94A6F-6743-4226-B5BC-0A92F1802B12

P3181

P356

SCIENCE.1210557

P1433

P1476

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

@en

P2093

Chetan Bettegowda

http://www.w3.org/2001/XMLSchema#string

Fausto J Rodriguez

http://www.w3.org/2001/XMLSchema#string

Gregory Riggins

http://www.w3.org/2001/XMLSchema#string

Hai Yan

http://www.w3.org/2001/XMLSchema#string

Laura D Wood

http://www.w3.org/2001/XMLSchema#string

Mark Sausen

http://www.w3.org/2001/XMLSchema#string

Nickolas Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Nishant Agrawal

http://www.w3.org/2001/XMLSchema#string

Sueli Mieko Oba-Shinjo

http://www.w3.org/2001/XMLSchema#string

Suely Kazue Nagahashi Marie

http://www.w3.org/2001/XMLSchema#string

P2860

A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling

A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif

An integrated genomic analysis of human glioblastoma multiforme

IDH1 and IDH2 mutations in gliomas

The consensus coding sequences of human breast and colorectal cancers

The genomic landscapes of human breast and colorectal cancers

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

P304

1453-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4297890

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCIENCE.1210557

http://www.w3.org/2001/XMLSchema#string

P407

P433

6048

http://www.w3.org/2001/XMLSchema#string

P478

333

http://www.w3.org/2001/XMLSchema#string

P50

Ralph H. Hruban

Kenneth W Kinzler

Daniel P Cahill

Darell D. Bigner

Victor Velculescu

Bert Vogelstein

Roger E McLendon

P577

2011-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51547596

http://www.w3.org/2001/XMLSchema#string

P698

21817013

http://www.w3.org/2001/XMLSchema#string

P921

oligodendroglioma

P932

3170506

http://www.w3.org/2001/XMLSchema#string